Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Intensive Care. 2012 Oct 12;2(1):43. doi: 10.1186/2110-5820-2-43.

A fresh look at paralytics in the critically ill: real promise and real concern.

Author information

  • 1Division of Pulmonary, Critical Care and Sleep Medicine, Univ, of California, Davis, 4150V, Street, Suite 3400, Sacramento, CA 95817, USA. nicholas.stollenwerk@ucdmc.ucdavis.edu.

Abstract

Neuromuscular blocking agents (NMBAs), or "paralytics," often are deployed in the sickest patients in the intensive care unit (ICU) when usual care fails. Despite the publication of guidelines on the use of NMBAs in the ICU in 2002, clinicians have needed more direction to determine which patients would benefit from NMBAs and which patients would be harmed. Recently, new evidence has shown that paralytics hold more promise when used in carefully selected lung injury patients for brief periods of time. When used in early acute respiratory distress syndrome (ARDS), NMBAs assist to establish a lung protective strategy, which leads to improved oxygenation, decreased pulmonary and systemic inflammation, and potentially improved mortality. It also is increasingly recognized that NMBAs can cause harm, particularly critical illness polyneuromyopathy (CIPM), when used for prolonged periods or in septic shock. In this review, we address several practical considerations for clinicians who use NMBAs in their practice. Ultimately, we conclude that NMBAs should be considered a lung protective adjuvant in early ARDS and that clinicians should consider using an alternative NMBA to the aminosteroids in septic shock with less severe lung injury pending further studies.

PMID:
23062076
[PubMed]
PMCID:
PMC3519794
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk